DiagnaMed has introduced a new generative artificial intelligence (AI) personal medical chatbot called Dr GenAI.
Powered by OpenAI’s ChatGPT, the new medical chatbot will help people receive rapid, personalised medical information based on their unique medical conditions.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Designed to provide natural, human-like chats, the chatbot is suitable for people looking for new health solution ideas or a better understanding of their symptoms.
Dr GenAI can also study a person using medical information, including vitals, lab test results and physical traits.
The new chatbot has been developed using the features of the generative AI brain health platform CERVAI, to target life science companies, licensed medical professionals, hospitals and patients.
It can also be integrated into the platform, allowing patients to access a full suite of solutions to enhance brain health.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataAccording to the company, Dr GenAI is not a substitute for doctors however and can commit errors.
DiagnaMed chairman and CEO Fabio Chianelli said: “We are excited to launch our third generative AI health solution, Dr GenAI, for people seeking health information based on their unique medical conditions.
“Dr GenAI aligns with our objective of developing and commercialising OpenAI ChatGPT-powered solutions for the healthcare market and incorporating them into our CERVAI generative AI brain health platform.”
DiagnaMed is focused on the commercialisation of the CERVAI and Health GenAI platforms to offer generative AI solutions for the healthcare market.
